<?xml version="1.0" encoding="utf-8"?>
<chapter id="c0025" version="5.3" docsubtype="chp" xml:lang="en" xmlns="http://www.elsevier.com/xml/bk/dtd"
         xmlns:ce="http://www.elsevier.com/xml/common/dtd" xmlns:xlink="http://www.w3.org/1999/xlink">
    <info>
        <ce:pii>B978-0-7234-3869-4.00005-7</ce:pii>
        <ce:doi>10.1016/B978-0-7234-3869-4.00005-7</ce:doi>
        <ce:isbn>978-0-7234-3869-4</ce:isbn>
        <ce:copyright type="full-transfer" year="2015">Elsevier Ltd</ce:copyright>
    </info>
    <ce:floats>
        <ce:figure id="f0010">
            <ce:label>Fig. 5.1</ce:label>
            <ce:caption id="ca0010">
                <ce:simple-para id="sp0010" role="title">Flowchart of different types of study design.</ce:simple-para>
            </ce:caption>
            <ce:link locator="f05-01-9780723437352" id="lk0010"/>
        </ce:figure>
        <ce:figure id="f0015">
            <ce:label>Fig. 5.2</ce:label>
            <ce:caption id="ca0015">
                <ce:simple-para id="sp0015" role="title">Study design timeline.</ce:simple-para>
            </ce:caption>
            <ce:link locator="f05-02-9780723437352" id="lk0015"/>
        </ce:figure>
        <ce:figure id="f0020">
            <ce:label>Fig. 5.3</ce:label>
            <ce:caption id="ca0020">
                <ce:simple-para id="sp0020" role="title">Association versus causation.</ce:simple-para>
            </ce:caption>
            <ce:link locator="f05-03-9780723437352" id="lk0020"/>
        </ce:figure>
        <ce:figure id="f0025">
            <ce:label>Fig. 5.4</ce:label>
            <ce:caption id="ca0025">
                <ce:simple-para id="sp0025" role="title">Flowchart for choosing the right type of study.
                </ce:simple-para>
            </ce:caption>
            <ce:link locator="f05-04-9780723437352" id="lk0025"/>
        </ce:figure>
        <ce:figure id="f0030">
            <ce:label>Fig. 5.5</ce:label>
            <ce:caption id="ca0030">
                <ce:simple-para id="sp0030" role="title">Evidence of causality: choosing the right type of study.
                </ce:simple-para>
            </ce:caption>
            <ce:link locator="f05-05-9780723437352" id="lk0030"/>
        </ce:figure>
    </ce:floats>
    <ce:label>Chapter 5</ce:label>
    <ce:title>Research design</ce:title>
    <objectives>
        <ce:section-title id="st0010">Objectives</ce:section-title>
        <ce:para id="p0010">By the end of this chapter you should:
            <ce:list id="l0010">
                <ce:list-item id="u0010">
                    <ce:label>•</ce:label>
                    <ce:para id="p0015">Understand the steps involved in obtaining data to answer a research question.
                    </ce:para>
                </ce:list-item>
                <ce:list-item id="u0015">
                    <ce:label>•</ce:label>
                    <ce:para id="p0020">Be able to explain the differences between an interventional and an
                        observational study design.
                    </ce:para>
                </ce:list-item>
                <ce:list-item id="u0020">
                    <ce:label>•</ce:label>
                    <ce:para id="p0025">Know the definition of a clinical trial and the differences between the various
                        clinical trial phases.
                    </ce:para>
                </ce:list-item>
                <ce:list-item id="u0025">
                    <ce:label>•</ce:label>
                    <ce:para id="p0030">Understand the differences between association and causality.</ce:para>
                </ce:list-item>
                <ce:list-item id="u0030">
                    <ce:label>•</ce:label>
                    <ce:para id="p0035">Know the steps involved in assessing whether there is a causal relationship
                        between an exposure and an outcome.
                    </ce:para>
                </ce:list-item>
                <ce:list-item id="u0035">
                    <ce:label>•</ce:label>
                    <ce:para id="p0040">Be able to discuss the factors that determine when a particular study design is
                        indicated.
                    </ce:para>
                </ce:list-item>
                <ce:list-item id="u0040">
                    <ce:label>•</ce:label>
                    <ce:para id="p0045">Understand the steps involved in writing up a research study and be able to
                        apply this knowledge to your own work.
                    </ce:para>
                </ce:list-item>
            </ce:list>
        </ce:para>
    </objectives>
    <ce:sections>
        <ce:section id="s0010">
            <ce:section-title id="st0015">OBTAINING DATA</ce:section-title>
            <ce:para id="p0050">
                <ce:list id="l0015">
                    <ce:list-item id="u0045">
                        <ce:label>•</ce:label>
                        <ce:para id="p0055">Before even thinking about how to summarise, display or analyse your data,
                            you must first decide on how you are going to collect your data!
                        </ce:para>
                    </ce:list-item>
                    <ce:list-item id="u0050">
                        <ce:label>•</ce:label>
                        <ce:para id="p0060">It is crucial to choose the best study design to investigate your research
                            question.
                        </ce:para>
                    </ce:list-item>
                    <ce:list-item id="u0055">
                        <ce:label>•</ce:label>
                        <ce:para id="p0065">Poorly designed studies may yield misleading results, wasting time, money
                            and resources in the process.
                        </ce:para>
                    </ce:list-item>
                    <ce:list-item id="u0060">
                        <ce:label>•</ce:label>
                        <ce:para id="p0070">There may be a number of possible study designs for any research question.
                        </ce:para>
                    </ce:list-item>
                    <ce:list-item id="u0065">
                        <ce:label>•</ce:label>
                        <ce:para id="p0075">Over the next few chapters you will learn about the major epidemiological
                            study designs currently being used in evidence-based practice today.
                        </ce:para>
                    </ce:list-item>
                    <ce:list-item id="u0070">
                        <ce:label>•</ce:label>
                        <ce:para id="p0080">Research studies can be classified into two types:
                            <ce:list id="l0020">
                                <ce:list-item id="o0010">
                                    <ce:label>1.</ce:label>
                                    <ce:para id="p0085">Interventional studies (or experimental studies)</ce:para>
                                </ce:list-item>
                                <ce:list-item id="o0015">
                                    <ce:label>2.</ce:label>
                                    <ce:para id="p0090">Observational studies.</ce:para>
                                </ce:list-item>
                            </ce:list>
                        </ce:para>
                    </ce:list-item>
                    <ce:list-item id="u0075">
                        <ce:label>•</ce:label>
                        <ce:para id="p0095">The flowchart presented in
                            <ce:cross-ref refid="f0010">Fig. 5.1</ce:cross-ref>
                            <ce:float-anchor refid="f0010"/>
                            summarises the different types of interventional and observational study designs.
                        </ce:para>
                    </ce:list-item>
                    <ce:list-item id="u0080">
                        <ce:label>•</ce:label>
                        <ce:para id="p0100">
                            <ce:cross-ref refid="f0015">Figure 5.2</ce:cross-ref>
                            <ce:float-anchor refid="f0015"/>
                            uses a timeline to illustrate the time points at which exposure and outcome data are
                            collected for some of the common types of study designs.
                        </ce:para>
                    </ce:list-item>
                    <ce:list-item id="u0085">
                        <ce:label>•</ce:label>
                        <ce:para id="p0105">Qualitative research can be carried out on its own or incorporated into a
                            quantitative study design.
                        </ce:para>
                    </ce:list-item>
                    <ce:list-item id="u0090">
                        <ce:label>•</ce:label>
                        <ce:para id="p0110">Each study design will be discussed in extensive detail in their respective
                            chapters.
                        </ce:para>
                    </ce:list-item>
                </ce:list>
            </ce:para>
        </ce:section>
        <ce:section id="s0015">
            <ce:section-title id="st0020">INTERVENTIONAL STUDIES</ce:section-title>
            <ce:para id="p0115">
                <ce:list id="l0025">
                    <ce:list-item id="u0095">
                        <ce:label>•</ce:label>
                        <ce:para id="p0120">An interventional (or experimental) study is when the investigator tests
                            whether intervening in some way leads to a measurable variation in the outcome.
                        </ce:para>
                    </ce:list-item>
                    <ce:list-item id="u0100">
                        <ce:label>•</ce:label>
                        <ce:para id="p0125">Interventional studies underpin clinical trials that compare two or more
                            treatments (see below).
                        </ce:para>
                    </ce:list-item>
                    <ce:list-item id="u0105">
                        <ce:label>•</ce:label>
                        <ce:para id="p0130">A laboratory study is another type of interventional study and may involve
                            carrying out research using animal models.
                        </ce:para>
                    </ce:list-item>
                    <ce:list-item id="u0110">
                        <ce:label>•</ce:label>
                        <ce:para id="p0135">Interventional studies provide data with a high degree of internal validity
                            (discussed in<ce:intra-ref xlink:href="pii:B978-0-7234-3869-4.00001-X" id="ia0010">Chapter
                                1</ce:intra-ref>), as it is generally possible to control for factors that may affect
                            the outcome.
                        </ce:para>
                    </ce:list-item>
                    <ce:list-item id="u0115">
                        <ce:label>•</ce:label>
                        <ce:para id="p0140">A high level of validity may be needed for studying an intervention that is
                            expected to have a small effect on the outcome. This small effect is usually defined as a
                            difference of up to 20% between the two intervention groups.
                        </ce:para>
                    </ce:list-item>
                    <ce:list-item id="u0120">
                        <ce:label>•</ce:label>
                        <ce:para id="p0145">When the difference between the two groups is relatively small, confounding
                            or bias may produce invalid findings, i.e. mask or create an effect.
                        </ce:para>
                    </ce:list-item>
                    <ce:list-item id="u0125">
                        <ce:label>•</ce:label>
                        <ce:para id="p0150">However, interventional studies are not always feasible, for example, due to
                            high running costs, patients’ reluctance to participate or ethical issues.
                        </ce:para>
                    </ce:list-item>
                    <ce:list-item id="u0130">
                        <ce:label>•</ce:label>
                        <ce:para id="p0155">The different types of interventional studies that will be reviewed in this
                            book are:
                            <ce:list id="l0030">
                                <ce:list-item id="u0135">
                                    <ce:label>•</ce:label>
                                    <ce:para id="p0160">Parallel randomised controlled trials (RCTs)</ce:para>
                                </ce:list-item>
                                <ce:list-item id="u0140">
                                    <ce:label>•</ce:label>
                                    <ce:para id="p0165">Crossover RCTs</ce:para>
                                </ce:list-item>
                                <ce:list-item id="u0145">
                                    <ce:label>•</ce:label>
                                    <ce:para id="p0170">Factorial RCTs</ce:para>
                                </ce:list-item>
                                <ce:list-item id="u9000">
                                    <ce:label>•</ce:label>
                                    <ce:para id="p9000">Cluster RCTs</ce:para>
                                </ce:list-item>
                                <ce:list-item id="u9005">
                                    <ce:label>•</ce:label>
                                    <ce:para id="p9005">Superiority RCTs</ce:para>
                                </ce:list-item>
                                <ce:list-item id="u9010">
                                    <ce:label>•</ce:label>
                                    <ce:para id="p9010">Equivalence RCTs</ce:para>
                                </ce:list-item>
                                <ce:list-item id="u9015">
                                    <ce:label>•</ce:label>
                                    <ce:para id="p9015">Non-inferiority RCTs</ce:para>
                                </ce:list-item>
                            </ce:list>
                        </ce:para>
                    </ce:list-item>
                    <ce:list-item id="u0150">
                        <ce:label>•</ce:label>
                        <ce:para id="p0175">In RCTs, only the play of chance (randomisation) determines the intervention
                            that is allocated to a particular subject. Consequently, large, well-designed RCTs provide
                            strong evidence that an association between an intervention and outcome is causal. We will
                            discuss this concept in greater detail in<ce:intra-ref
                                    xlink:href="pii:B978-0-7234-3869-4.00006-9" id="ia0015">Chapter 6</ce:intra-ref>.
                        </ce:para>
                    </ce:list-item>
                </ce:list>
            </ce:para>
        </ce:section>
        <ce:section id="s0020">
            <ce:section-title id="st0025">OBSERVATIONAL STUDIES</ce:section-title>
            <ce:para id="p0180">
                <ce:list id="l0035">
                    <ce:list-item id="u0155">
                        <ce:label>•</ce:label>
                        <ce:para id="p0185">An observational study is when the investigator collects data on exposures
                            and outcomes without attempting to alter a subject's exposure status.
                        </ce:para>
                    </ce:list-item>
                    <ce:list-item id="u0160">
                        <ce:label>•</ce:label>
                        <ce:para id="p0190">Patterns and associations between exposures and outcomes are identified
                            using naturally occurring variation in the population.
                        </ce:para>
                    </ce:list-item>
                    <ce:list-item id="u0165">
                        <ce:label>•</ce:label>
                        <ce:para id="p0195">Compared to interventional studies, observational studies can be used to
                            study the effect of a wider range of exposures, including studying the natural history,
                            prevention and treatment of a disease. Consequently, there is a role for observational
                            studies in clinical trials (see below).
                        </ce:para>
                    </ce:list-item>
                    <ce:list-item id="u0170">
                        <ce:label>•</ce:label>
                        <ce:para id="p0200">Investigating the natural history of a disease may involve collecting data
                            on:
                            <ce:list id="l0040">
                                <ce:list-item id="u0175">
                                    <ce:label>•</ce:label>
                                    <ce:para id="p0205">the causes of disease incidence</ce:para>
                                </ce:list-item>
                                <ce:list-item id="u0180">
                                    <ce:label>•</ce:label>
                                    <ce:para id="p0210">the determinants of disease progression.</ce:para>
                                </ce:list-item>
                            </ce:list>
                        </ce:para>
                    </ce:list-item>
                    <ce:list-item id="u0185">
                        <ce:label>•</ce:label>
                        <ce:para id="p0215">Understanding the natural history of a disease can allow us to predict the
                            future healthcare needs of a population.
                        </ce:para>
                    </ce:list-item>
                    <ce:list-item id="u0190">
                        <ce:label>•</ce:label>
                        <ce:para id="p0220">However, observational studies have lower internal validity than
                            interventional studies. This is because the investigator has no control over factors that
                            may affect the outcome.
                        </ce:para>
                    </ce:list-item>
                    <ce:list-item id="u0195">
                        <ce:label>•</ce:label>
                        <ce:para id="p0225">Despite this limitation, in some situations, observational studies are the
                            only types of study that are practical.
                        </ce:para>
                    </ce:list-item>
                    <ce:list-item id="u0200">
                        <ce:label>•</ce:label>
                        <ce:para id="p0230">The different types of observational studies that will be reviewed in this
                            book are:
                            <ce:list id="l0045">
                                <ce:list-item id="u0205">
                                    <ce:label>•</ce:label>
                                    <ce:para id="p0235">Cohort studies</ce:para>
                                </ce:list-item>
                                <ce:list-item id="u0210">
                                    <ce:label>•</ce:label>
                                    <ce:para id="p0240">Case–control studies</ce:para>
                                </ce:list-item>
                                <ce:list-item id="u0215">
                                    <ce:label>•</ce:label>
                                    <ce:para id="p0245">Cross-sectional studies</ce:para>
                                </ce:list-item>
                                <ce:list-item id="u0220">
                                    <ce:label>•</ce:label>
                                    <ce:para id="p0250">Ecological studies</ce:para>
                                </ce:list-item>
                                <ce:list-item id="u0225">
                                    <ce:label>•</ce:label>
                                    <ce:para id="p0255">Case studies and case series.</ce:para>
                                </ce:list-item>
                            </ce:list>
                        </ce:para>
                    </ce:list-item>
                </ce:list>
                <ce:display>
                    <ce:textbox role="alt1" id="b0010">
                        <ce:textbox-head>
                            <ce:title>COMMUNICATION</ce:title>
                            <ce:subtitle>When would you choose an observational study design over an interventional
                                study design?
                            </ce:subtitle>
                        </ce:textbox-head>
                        <ce:textbox-body>
                            <ce:sections>
                                <ce:para id="p0260">You may consider using an observational study design to answer a
                                    specific research question if the equivalent interventional study design is:
                                    <ce:list id="l0050">
                                        <ce:list-item id="u0230">
                                            <ce:label>•</ce:label>
                                            <ce:para id="p0265">unethical, e.g. randomly allocating healthy people to
                                                radiation, to investigate whether exposure to radiation leads to a
                                                higher risk of cancer.
                                            </ce:para>
                                        </ce:list-item>
                                        <ce:list-item id="u0235">
                                            <ce:label>•</ce:label>
                                            <ce:para id="p0270">inappropriate, e.g. are homosexual men at higher risk of
                                                acquiring HIV infection than heterosexual men?
                                            </ce:para>
                                        </ce:list-item>
                                        <ce:list-item id="u0240">
                                            <ce:label>•</ce:label>
                                            <ce:para id="p0275">too expensive.</ce:para>
                                        </ce:list-item>
                                        <ce:list-item id="u0245">
                                            <ce:label>•</ce:label>
                                            <ce:para id="p0280">unlikely to yield a significant result, e.g. for
                                                studying rare events such as a rare side effect of a drug.
                                            </ce:para>
                                        </ce:list-item>
                                        <ce:list-item id="u0250">
                                            <ce:label>•</ce:label>
                                            <ce:para id="p0285">impracticable (unfeasible), e.g. is working on regular
                                                night shifts associated with a higher risk of ischaemic heart disease?
                                            </ce:para>
                                        </ce:list-item>
                                    </ce:list>
                                </ce:para>
                            </ce:sections>
                        </ce:textbox-body>
                    </ce:textbox>
                </ce:display>
            </ce:para>
        </ce:section>
        <ce:section id="s0025">
            <ce:section-title id="st0030">CLINICAL TRIALS</ce:section-title>
            <ce:para id="p0290">
                <ce:list id="l0055">
                    <ce:list-item id="u0255">
                        <ce:label>•</ce:label>
                        <ce:para id="p0295">Although there are many definitions of clinical trials, according to the
                            National Institutes of Health ClinicalTrials.gov website (2012), they are ‘generally
                            considered to be biomedical or health-related research studies in human beings that follow a
                            pre-defined protocol’. They include ‘both interventional and observational types of
                            studies’.
                        </ce:para>
                    </ce:list-item>
                </ce:list>
            </ce:para>
            <ce:section id="s0030">
                <ce:section-title id="st0035">Types of clinical trials</ce:section-title>
                <ce:para id="p0300">
                    <ce:list id="l0060">
                        <ce:list-item id="u0260">
                            <ce:label>•</ce:label>
                            <ce:para id="p0305">The National Institutes of Health defines five different types of
                                clinical trials:
                                <ce:list id="l0065">
                                    <ce:list-item id="o0020">
                                        <ce:label>1.</ce:label>
                                        <ce:para id="p0310">
                                            <ce:italic>Treatment trials</ce:italic>
                                            – Involve testing new interventions (e.g. drugs, a new surgery procedure, a
                                            new radiological approach) or a combination of interventions
                                        </ce:para>
                                    </ce:list-item>
                                    <ce:list-item id="o0025">
                                        <ce:label>2.</ce:label>
                                        <ce:para id="p0315">
                                            <ce:italic>Prevention trials</ce:italic>
                                            – Involve investigating methods for the primary prevention (methods for
                                            preventing healthy people from developing a disease), secondary prevention
                                            (methods for slowing down the progression of a disease or for treating it in
                                            its early stage whilst the patient is still asymptomatic) and tertiary
                                            prevention (methods for preventing further physical deterioration in chronic
                                            symptomatic disease states) of a disease. These methods may include drugs,
                                            vaccines, lifestyle changes, etc.
                                        </ce:para>
                                    </ce:list-item>
                                    <ce:list-item id="o0030">
                                        <ce:label>3.</ce:label>
                                        <ce:para id="p0320">
                                            <ce:italic>Diagnostic trials</ce:italic>
                                            – Involve investigating better procedures or tests for diagnosing a
                                            particular disease or condition.
                                        </ce:para>
                                    </ce:list-item>
                                    <ce:list-item id="o0035">
                                        <ce:label>4.</ce:label>
                                        <ce:para id="p0325">
                                            <ce:italic>Screening trials</ce:italic>
                                            – Involve investigating ways for detecting a particular disease or health
                                            condition.
                                        </ce:para>
                                    </ce:list-item>
                                    <ce:list-item id="o0040">
                                        <ce:label>5.</ce:label>
                                        <ce:para id="p0330">
                                            <ce:italic>Quality of life trials</ce:italic>
                                            – Involve exploring ways for improving the quality of life for individuals
                                            with a chronic disease.
                                        </ce:para>
                                    </ce:list-item>
                                </ce:list>
                            </ce:para>
                        </ce:list-item>
                    </ce:list>
                </ce:para>
            </ce:section>
            <ce:section id="s0035">
                <ce:section-title id="st0040">Clinical trial phases</ce:section-title>
                <ce:para id="p0335">
                    <ce:list id="l0070">
                        <ce:list-item id="u0265">
                            <ce:label>•</ce:label>
                            <ce:para id="p0340">Several clinical trial phases must be followed to ensure new drugs or
                                treatments are safe and effective prior to incorporating them into clinical guidelines.
                            </ce:para>
                        </ce:list-item>
                        <ce:list-item id="u0270">
                            <ce:label>•</ce:label>
                            <ce:para id="p0345">The trials at each phase have a different purpose, helping
                                scientists/clinicians answer different questions.
                            </ce:para>
                        </ce:list-item>
                        <ce:list-item id="u0275">
                            <ce:label>•</ce:label>
                            <ce:para id="p0350">We will go through the stages involved in turn, using the example of a
                                new drug therapy to illustrate our points.
                            </ce:para>
                        </ce:list-item>
                    </ce:list>
                </ce:para>
                <ce:section id="s0040">
                    <ce:section-title id="st0045">Pre-clinical trials</ce:section-title>
                    <ce:para id="p0355">
                        <ce:list id="l0075">
                            <ce:list-item id="u0280">
                                <ce:label>•</ce:label>
                                <ce:para id="p0360">Prior to starting clinic trials on a novel drug in humans, the first
                                    step is to show that it has some potential to be the next big thing! We demonstrate
                                    this by using in vitro (test tube experiments) and in vivo (animal studies)
                                    techniques at a laboratory to obtain preliminary toxicity, efficacy and
                                    pharmacokinetic information.
                                </ce:para>
                            </ce:list-item>
                        </ce:list>
                    </ce:para>
                </ce:section>
                <ce:section id="s0045">
                    <ce:section-title id="st0050">Phase I trials</ce:section-title>
                    <ce:para id="p0365">
                        <ce:list id="l0080">
                            <ce:list-item id="u0285">
                                <ce:label>•</ce:label>
                                <ce:para id="p0370">Once laboratory experiments show that a new drug has promise, the
                                    next step is to test its safety in humans.
                                </ce:para>
                            </ce:list-item>
                            <ce:list-item id="u0290">
                                <ce:label>•</ce:label>
                                <ce:para id="p0375">Phase I trials often involve only a small number of individuals
                                    (20–60), some of whom may be healthy volunteers.
                                </ce:para>
                            </ce:list-item>
                            <ce:list-item id="u0295">
                                <ce:label>•</ce:label>
                                <ce:para id="p0380">Phase I cancer trials often involve patients with advanced cancer
                                    who have already exhausted all current treatment options available to them, without
                                    much benefit.
                                </ce:para>
                            </ce:list-item>
                            <ce:list-item id="u0300">
                                <ce:label>•</ce:label>
                                <ce:para id="p0385">The protocol may involve giving very low doses of the new drug to
                                    the first group (or ‘cohort’) of patients and gradually increasing the doses for
                                    later groups.
                                </ce:para>
                            </ce:list-item>
                            <ce:list-item id="u0305">
                                <ce:label>•</ce:label>
                                <ce:para id="p0390">Using this dose escalation protocol allows researchers to identify:
                                    <ce:list id="l0085">
                                        <ce:list-item id="o0045">
                                            <ce:label>1.</ce:label>
                                            <ce:para id="p0395">the safe dose range in humans</ce:para>
                                        </ce:list-item>
                                        <ce:list-item id="o0050">
                                            <ce:label>2.</ce:label>
                                            <ce:para id="p0400">the side-effect profile of the drug.</ce:para>
                                        </ce:list-item>
                                    </ce:list>
                                </ce:para>
                            </ce:list-item>
                            <ce:list-item id="u0310">
                                <ce:label>•</ce:label>
                                <ce:para id="p0405">These studies also involve investigating the most effective way of
                                    delivering the new drug, e.g. orally, intramuscularly, intravenously,
                                    subcutaneously, etc.
                                </ce:para>
                            </ce:list-item>
                            <ce:list-item id="u0315">
                                <ce:label>•</ce:label>
                                <ce:para id="p0410">If the new drug has been found to be reasonably safe, it can
                                    subsequently be tested in phase II clinical trials.
                                </ce:para>
                            </ce:list-item>
                        </ce:list>
                    </ce:para>
                </ce:section>
                <ce:section id="s0050">
                    <ce:section-title id="st0055">Phase II trials</ce:section-title>
                    <ce:para id="p0415">
                        <ce:list id="l0090">
                            <ce:list-item id="u0320">
                                <ce:label>•</ce:label>
                                <ce:para id="p0420">Phase II trials test the new drug in a larger group of people
                                    (100–300) to investigate whether it is effective (at least in the short term) and to
                                    further evaluate its safety profile.
                                </ce:para>
                            </ce:list-item>
                            <ce:list-item id="u0325">
                                <ce:label>•</ce:label>
                                <ce:para id="p0425">The methods used to assess how well the new treatment works depends
                                    on the disease type. For example, imaging techniques (e.g. X-rays, CT scans, MRI
                                    etc.) may be used to show whether a tumour is shrinking.
                                </ce:para>
                            </ce:list-item>
                            <ce:list-item id="u0330">
                                <ce:label>•</ce:label>
                                <ce:para id="p0430">The people chosen for phase II trials usually have the disease for
                                    which the drug is targeted.
                                </ce:para>
                            </ce:list-item>
                            <ce:list-item id="u0335">
                                <ce:label>•</ce:label>
                                <ce:para id="p0435">If the new drug shows an effect, and is shown to be safe enough, it
                                    can be then tested in phase III clinical trials.
                                </ce:para>
                            </ce:list-item>
                        </ce:list>
                    </ce:para>
                </ce:section>
                <ce:section id="s0055">
                    <ce:section-title id="st0060">Phase III trials</ce:section-title>
                    <ce:para id="p0440">
                        <ce:list id="l0095">
                            <ce:list-item id="u0340">
                                <ce:label>•</ce:label>
                                <ce:para id="p0445">Phase III trials usually involve comparing the new drug with the
                                    gold standard treatment (discussed in<ce:intra-ref
                                            xlink:href="pii:B978-0-7234-3869-4.00014-8" id="ia0020">Chapter
                                        14</ce:intra-ref>) currently in use, or with a placebo.
                                </ce:para>
                            </ce:list-item>
                            <ce:list-item id="u0345">
                                <ce:label>•</ce:label>
                                <ce:para id="p0450">Often these trials use a ‘randomised controlled trial’ study design
                                    whereby participants have an equal chance of being assigned to either the new drug
                                    or gold standard treatment (or placebo). Please refer to
                                    <ce:intra-ref xlink:href="pii:B978-0-7234-3869-4.00006-9" id="ia0025">Chapter 6
                                    </ce:intra-ref>
                                    for an in-depth discussion on RCTs.
                                </ce:para>
                            </ce:list-item>
                            <ce:list-item id="u0350">
                                <ce:label>•</ce:label>
                                <ce:para id="p0455">The main objective is to learn whether the new drug is better than,
                                    the same as or worse than the standard treatment.
                                </ce:para>
                            </ce:list-item>
                            <ce:list-item id="u0355">
                                <ce:label>•</ce:label>
                                <ce:para id="p0460">They also build on knowledge from the previous two trial phases
                                    regarding the safety and side-effect profile of the new drug.
                                </ce:para>
                            </ce:list-item>
                            <ce:list-item id="u0360">
                                <ce:label>•</ce:label>
                                <ce:para id="p0465">Phase III trials involve several thousand patients (1000–3000 or
                                    more), sometimes across different hospitals in different countries.
                                </ce:para>
                            </ce:list-item>
                            <ce:list-item id="u0365">
                                <ce:label>•</ce:label>
                                <ce:para id="p0470">The smaller the expected difference in effect size between the new
                                    drug and the standard treatment (or placebo), the greater the number of participants
                                    required for the trial to show this difference.
                                </ce:para>
                            </ce:list-item>
                            <ce:list-item id="u0370">
                                <ce:label>•</ce:label>
                                <ce:para id="p0475">Underpinned by ethical principle, an RCT will be stopped early if
                                    the side effects of the new treatment are too severe or if the outcome in one group
                                    (not necessarily the new treatment group) is better than the outcome in the other
                                    group(s).
                                </ce:para>
                            </ce:list-item>
                            <ce:list-item id="u0375">
                                <ce:label>•</ce:label>
                                <ce:para id="p0480">Phase III trials are needed before the new drug can be considered
                                    for use in routine clinical practice.
                                </ce:para>
                            </ce:list-item>
                        </ce:list>
                    </ce:para>
                </ce:section>
                <ce:section id="s0060">
                    <ce:section-title id="st0065">Phase IV trials</ce:section-title>
                    <ce:para id="p0485">
                        <ce:list id="l0100">
                            <ce:list-item id="u0380">
                                <ce:label>•</ce:label>
                                <ce:para id="p0490">Phase IV trials are carried out after the drug has been licensed,
                                    marketed and made available for all patients.
                                </ce:para>
                            </ce:list-item>
                            <ce:list-item id="u0385">
                                <ce:label>•</ce:label>
                                <ce:para id="p0495">The main objective of phase IV trials is to gather information on:
                                    <ce:list id="l0105">
                                        <ce:list-item id="u0390">
                                            <ce:label>•</ce:label>
                                            <ce:para id="p0500">how well the drug works in various populations.
                                            </ce:para>
                                        </ce:list-item>
                                        <ce:list-item id="u0395">
                                            <ce:label>•</ce:label>
                                            <ce:para id="p0505">the long-term risks and benefits of taking the drug.
                                            </ce:para>
                                        </ce:list-item>
                                        <ce:list-item id="u0400">
                                            <ce:label>•</ce:label>
                                            <ce:para id="p0510">the side effects and safety of the drug in larger
                                                populations.
                                            </ce:para>
                                        </ce:list-item>
                                        <ce:list-item id="u0405">
                                            <ce:label>•</ce:label>
                                            <ce:para id="p0515">whether the drug can be used in combination with other
                                                treatments.
                                            </ce:para>
                                        </ce:list-item>
                                    </ce:list>
                                </ce:para>
                            </ce:list-item>
                            <ce:list-item id="u0410">
                                <ce:label>•</ce:label>
                                <ce:para id="p0520">These studies typically use an observational study design.</ce:para>
                            </ce:list-item>
                        </ce:list>
                    </ce:para>
                </ce:section>
            </ce:section>
        </ce:section>
        <ce:section id="s0065">
            <ce:section-title id="st0070">BRADFORD-HILL CRITERIA FOR CAUSATION</ce:section-title>
            <ce:para id="p0525">
                <ce:list id="l0110">
                    <ce:list-item id="u0415">
                        <ce:label>•</ce:label>
                        <ce:para id="p0530">Due to the nature of the study design, consistent evidence from RCTs will
                            usually lead us to conclude that there is a causal relationship between the intervention
                            (exposure) and the disease outcome.
                        </ce:para>
                    </ce:list-item>
                    <ce:list-item id="u0420">
                        <ce:label>•</ce:label>
                        <ce:para id="p0535">However, due to issues regarding the internal validity of observational
                            studies, assessing for causation is less straightforward.
                        </ce:para>
                    </ce:list-item>
                    <ce:list-item id="u0425">
                        <ce:label>•</ce:label>
                        <ce:para id="p0540">Suppose we carry out an observational study to investigate whether smoking
                            causes lung cancer. We use a cohort study design and collect the relevant data, comparing
                            the incidence of lung cancer in smokers and in non-smokers. To exclude the role of chance we
                            carry out a statistical test, which yields a<ce:italic>P</ce:italic>-value<ce:hsp
                                    sp="0.12"/>&lt;<ce:hsp sp="0.12"/>0.05, thus providing evidence that the study is
                            externally valid. Can we therefore conclude that smoking causes lung cancer? NOOOOOOOO!!!
                            Well, not yet!
                        </ce:para>
                    </ce:list-item>
                    <ce:list-item id="u0430">
                        <ce:label>•</ce:label>
                        <ce:para id="p0545">As discussed in<ce:intra-ref xlink:href="pii:B978-0-7234-3869-4.00001-X"
                                                                         id="ia0030">Chapter 1</ce:intra-ref>, we must
                            first determine the internal validity of the study. This involves ensuring that the study
                            was run carefully (research design, how variables were measured, etc.) and that the observed
                            effect(s) are likely to be produced solely by the intervention being assessed (and not by
                            another factor).
                        </ce:para>
                    </ce:list-item>
                    <ce:list-item id="u0435">
                        <ce:label>•</ce:label>
                        <ce:para id="p0550">The three main threats to internal validity are:
                            <ce:list id="l0115">
                                <ce:list-item id="u0440">
                                    <ce:label>•</ce:label>
                                    <ce:para id="p0555">confounding</ce:para>
                                </ce:list-item>
                                <ce:list-item id="u0445">
                                    <ce:label>•</ce:label>
                                    <ce:para id="p0560">bias</ce:para>
                                </ce:list-item>
                                <ce:list-item id="u0450">
                                    <ce:label>•</ce:label>
                                    <ce:para id="p0565">causality.</ce:para>
                                </ce:list-item>
                            </ce:list>
                        </ce:para>
                    </ce:list-item>
                    <ce:list-item id="u0455">
                        <ce:label>•</ce:label>
                        <ce:para id="p0570">We exclude bias (discussed in<ce:intra-ref
                                xlink:href="pii:B978-0-7234-3869-4.00007-0" id="ia0035">Chapter 7</ce:intra-ref>) and
                            confounding (discussed in<ce:intra-ref xlink:href="pii:B978-0-7234-3869-4.00013-6"
                                                                   id="ia0040">Chapter 13</ce:intra-ref>) as the likely
                            explanation for our findings. At this stage, we can safely conclude that there is a true
                            <ce:italic>association</ce:italic>
                            between smoking and lung cancer.
                        </ce:para>
                    </ce:list-item>
                    <ce:list-item id="u0460">
                        <ce:label>•</ce:label>
                        <ce:para id="p0575">Association, however, does not mean causation.</ce:para>
                    </ce:list-item>
                    <ce:list-item id="u0465">
                        <ce:label>•</ce:label>
                        <ce:para id="p0580">In 1965, Austin Bradford-Hill proposed a series of considerations to help
                            assess evidence of causation, which are known as the ‘Bradford-Hill criteria’.
                        </ce:para>
                    </ce:list-item>
                    <ce:list-item id="u0470">
                        <ce:label>•</ce:label>
                        <ce:para id="p0585">These criteria serve as a guide and do not all need to be fulfilled before
                            concluding that the relationship between two variables is causal.
                        </ce:para>
                    </ce:list-item>
                    <ce:list-item id="u0475">
                        <ce:label>•</ce:label>
                        <ce:para id="p0590">Observational studies can never establish that the relationship between two
                            variables is causal. To demonstrate this point, let's return to the cohort study example
                            discussed in
                            <ce:intra-ref xlink:href="pii:B978-0-7234-3869-4.00007-0" id="ia0045">Chapter 7
                            </ce:intra-ref>
                            under the ‘Confounding’ subsection. A well-conducted cohort study showed that taking hormone
                            replacement therapy (HRT) was associated with a reduced risk of coronary heart disease
                            (CHD). However, a subsequent RCT showed that HRT does not reduce the risk of CHD. It turned
                            out that women who took HRT were also more likely to be living a healthy lifestyle, and it
                            was this that led to a reduction in CHD. Therefore, due to issues regarding the internal
                            validity of observational studies, we must rely on well-conducted RCTs to establish a causal
                            relationship between two variables.
                        </ce:para>
                    </ce:list-item>
                    <ce:list-item id="u0480">
                        <ce:label>•</ce:label>
                        <ce:para id="p0595">
                            <ce:cross-ref refid="f0020">Figure 5.3</ce:cross-ref>
                            <ce:float-anchor refid="f0020"/>
                            summarises the steps involved in assessing whether there is an association or causation
                            between two variables. You must rely on evidence from multiple studies when assessing for
                            evidence of causation. Let's go through the checklist of criteria in turn.
                        </ce:para>
                    </ce:list-item>
                </ce:list>
            </ce:para>
            <ce:section id="s0070">
                <ce:section-title id="st0075">Strength of association</ce:section-title>
                <ce:para id="p0600">
                    <ce:list id="l0120">
                        <ce:list-item id="u0485">
                            <ce:label>•</ce:label>
                            <ce:para id="p0605">The strength of the association is defined by the actual size of the
                                association between two variables, as measured using the appropriate statistical test.
                            </ce:para>
                        </ce:list-item>
                        <ce:list-item id="u0490">
                            <ce:label>•</ce:label>
                            <ce:para id="p0610">The stronger the association:
                                <ce:list id="l0125">
                                    <ce:list-item id="u0495">
                                        <ce:label>•</ce:label>
                                        <ce:para id="p0615">the more likely that the relationship between the two
                                            variables is causal.
                                        </ce:para>
                                    </ce:list-item>
                                    <ce:list-item id="u0500">
                                        <ce:label>•</ce:label>
                                        <ce:para id="p0620">the less likely the relationship is due to confounding or
                                            bias.
                                        </ce:para>
                                    </ce:list-item>
                                </ce:list>
                            </ce:para>
                        </ce:list-item>
                        <ce:list-item id="u0505">
                            <ce:label>•</ce:label>
                            <ce:para id="p0625">A small association does not rule out a casual effect. There is still an
                                association!
                            </ce:para>
                        </ce:list-item>
                        <ce:list-item id="u0510">
                            <ce:label>•</ce:label>
                            <ce:para id="p0630">Regarding risk ratios (discussed in<ce:intra-ref
                                    xlink:href="pii:B978-0-7234-3869-4.00007-0" id="ia0050">Chapter 7</ce:intra-ref>),
                                those under 1.5 are generally regarded as pretty weak whilst those greater than 4.0 are
                                strong.
                            </ce:para>
                        </ce:list-item>
                    </ce:list>
                </ce:para>
            </ce:section>
            <ce:section id="s0075">
                <ce:section-title id="st0080">Consistency</ce:section-title>
                <ce:para id="p0635">
                    <ce:list id="l0130">
                        <ce:list-item id="u0515">
                            <ce:label>•</ce:label>
                            <ce:para id="p0640">The association is consistent when the results are replicated:
                                <ce:list id="l0135">
                                    <ce:list-item id="u0520">
                                        <ce:label>•</ce:label>
                                        <ce:para id="p0645">by different people</ce:para>
                                    </ce:list-item>
                                    <ce:list-item id="u0525">
                                        <ce:label>•</ce:label>
                                        <ce:para id="p0650">in different places</ce:para>
                                    </ce:list-item>
                                    <ce:list-item id="u0530">
                                        <ce:label>•</ce:label>
                                        <ce:para id="p0655">using different populations</ce:para>
                                    </ce:list-item>
                                    <ce:list-item id="u0535">
                                        <ce:label>•</ce:label>
                                        <ce:para id="p0660">using different study designs.</ce:para>
                                    </ce:list-item>
                                </ce:list>
                            </ce:para>
                        </ce:list-item>
                        <ce:list-item id="u0540">
                            <ce:label>•</ce:label>
                            <ce:para id="p0665">Numerous studies must be carried out before a statement can be made
                                about the causal relationship between two variables. However, because different exposure
                                levels and other parameters may reduce the effect of the causal factor, a lack of
                                consistency doesn't automatically rule out a causal association.
                            </ce:para>
                        </ce:list-item>
                    </ce:list>
                </ce:para>
            </ce:section>
            <ce:section id="s0080">
                <ce:section-title id="st0085">Specificity</ce:section-title>
                <ce:para id="p0670">
                    <ce:list id="l0140">
                        <ce:list-item id="u0545">
                            <ce:label>•</ce:label>
                            <ce:para id="p0675">An association is specific if there is a one-to-one relationship between
                                the cause and outcome. In other words, in the ideal situation, a single putative cause
                                produces a specific effect. However, this is not always the case in medicine, where most
                                exposures (e.g. smoking, diet) lead to numerous outcomes (e.g. lung cancer, heart
                                disease).
                            </ce:para>
                        </ce:list-item>
                        <ce:list-item id="u0550">
                            <ce:label>•</ce:label>
                            <ce:para id="p0680">Absence of specificity in no way negates a causal relationship.
                            </ce:para>
                        </ce:list-item>
                    </ce:list>
                </ce:para>
            </ce:section>
            <ce:section id="s0085">
                <ce:section-title id="st0090">Temporal sequence</ce:section-title>
                <ce:para id="p0685">
                    <ce:list id="l0145">
                        <ce:list-item id="u0555">
                            <ce:label>•</ce:label>
                            <ce:para id="p0690">The exposure
                                <ce:italic>must</ce:italic>
                                always precede the outcome. If there is an expected delay between the exposure and
                                effect, then the effect must occur after that delay. This is the only absolutely
                                essential criterion.
                            </ce:para>
                        </ce:list-item>
                        <ce:list-item id="u0560">
                            <ce:label>•</ce:label>
                            <ce:para id="p0695">The study design sometimes dictates whether it is easy to establish
                                temporality. For example, as the exposure is measured at the start of the study, the
                                temporal relationship between exposure and outcome is clear in prospective cohort
                                studies.
                            </ce:para>
                        </ce:list-item>
                        <ce:list-item id="u0565">
                            <ce:label>•</ce:label>
                            <ce:para id="p0700">When measurements of the putative cause and the effect are made at the
                                same time, as is the case in cross-sectional and case–control studies, it is difficult
                                to establish a temporal sequence between the exposure and outcome; therefore, ‘reverse
                                causality’ may be an issue. For example, case–control studies have shown that the
                                inflammatory marker C-reactive protein (CRP) is higher in patients who have had a
                                myocardial infarction. For a while, there was a feasible hypothesis that CRP levels
                                could be used as a biomarker of myocardial infarction risk. However, clever Mendelian
                                randomisation studies refuted this hypothesis. Instead, the inflammatory process
                                associated with myocardial infarction was causing an increase in the levels of CRP (not
                                the other way around).
                            </ce:para>
                        </ce:list-item>
                    </ce:list>
                </ce:para>
            </ce:section>
            <ce:section id="s0090">
                <ce:section-title id="st0095">Biological gradient (dose–response)</ce:section-title>
                <ce:para id="p0705">
                    <ce:list id="l0150">
                        <ce:list-item id="u0570">
                            <ce:label>•</ce:label>
                            <ce:para id="p0710">There should be a direct relationship between the level of exposure and
                                the risk of disease (or incidence of effect). This relationship may not be a simple
                                linear relationship.
                            </ce:para>
                        </ce:list-item>
                        <ce:list-item id="u0575">
                            <ce:label>•</ce:label>
                            <ce:para id="p0715">In some cases, greater exposure leads to a lower incidence of effect.
                                The presence of a dose–response relationship provides strong evidence that a causal
                                relationship exists.
                            </ce:para>
                        </ce:list-item>
                        <ce:list-item id="u0580">
                            <ce:label>•</ce:label>
                            <ce:para id="p0720">However, as with specificity (discussed above), the absence of a
                                dose–response relationship does not rule out a causal relationship. This is because in
                                some cases, the mere presence of the exposure can trigger the effect.
                            </ce:para>
                        </ce:list-item>
                        <ce:list-item id="u0585">
                            <ce:label>•</ce:label>
                            <ce:para id="p0725">Conversely, a relationship may only exist above a certain exposure
                                threshold.
                            </ce:para>
                        </ce:list-item>
                    </ce:list>
                </ce:para>
            </ce:section>
            <ce:section id="s0095">
                <ce:section-title id="st0100">Biological plausibility</ce:section-title>
                <ce:para id="p0730">
                    <ce:list id="l0155">
                        <ce:list-item id="u0590">
                            <ce:label>•</ce:label>
                            <ce:para id="p0735">The apparent cause and effect must be plausible in the light of current
                                knowledge. For example, is there a biological mechanism by which the exposure alters the
                                risk of a disease?
                            </ce:para>
                        </ce:list-item>
                        <ce:list-item id="u0595">
                            <ce:label>•</ce:label>
                            <ce:para id="p0740">If a biological explanation appears to be outside the scope of current
                                scientific knowledge, additional studies may be required before a true mechanism can be
                                postulated. Consequently, the lack of a known mechanism should not rule out causality.
                            </ce:para>
                        </ce:list-item>
                    </ce:list>
                </ce:para>
            </ce:section>
            <ce:section id="s0100">
                <ce:section-title id="st0105">Coherence</ce:section-title>
                <ce:para id="p0745">
                    <ce:list id="l0160">
                        <ce:list-item id="u0600">
                            <ce:label>•</ce:label>
                            <ce:para id="p0750">The association must be coherent with our existing knowledge within the
                                relevant field.
                            </ce:para>
                        </ce:list-item>
                        <ce:list-item id="u0605">
                            <ce:label>•</ce:label>
                            <ce:para id="p0755">There should be no competing or conflicting information.</ce:para>
                        </ce:list-item>
                    </ce:list>
                </ce:para>
            </ce:section>
            <ce:section id="s0105">
                <ce:section-title id="st0110">Reversibility (experimental evidence)</ce:section-title>
                <ce:para id="p0760">
                    <ce:list id="l0165">
                        <ce:list-item id="u0610">
                            <ce:label>•</ce:label>
                            <ce:para id="p0765">Removing the exposure should reduce or prevent the disease outcome.
                            </ce:para>
                        </ce:list-item>
                        <ce:list-item id="u0615">
                            <ce:label>•</ce:label>
                            <ce:para id="p0770">Ideally, such evidence should come from RCTs.</ce:para>
                        </ce:list-item>
                    </ce:list>
                </ce:para>
            </ce:section>
            <ce:section id="s0110">
                <ce:section-title id="st0115">Analogy</ce:section-title>
                <ce:para id="p0775">
                    <ce:list id="l0170">
                        <ce:list-item id="u0620">
                            <ce:label>•</ce:label>
                            <ce:para id="p0780">It is necessary to determine whether other factors similar (or
                                analogous) to the putative cause may also be causing the effect. For example, does a
                                similar drug have the same effect on the disease outcome?
                            </ce:para>
                        </ce:list-item>
                        <ce:list-item id="u0625">
                            <ce:label>•</ce:label>
                            <ce:para id="p0785">Bradford-Hill suggests that existing similar associations would support
                                causation.
                            </ce:para>
                        </ce:list-item>
                    </ce:list>
                </ce:para>
            </ce:section>
        </ce:section>
        <ce:section id="s0115">
            <ce:section-title id="st0120">CHOOSING THE RIGHT STUDY DESIGN</ce:section-title>
            <ce:para id="p0790">
                <ce:list id="l0175">
                    <ce:list-item id="u0630">
                        <ce:label>•</ce:label>
                        <ce:para id="p0795">There are a number of factors that must be taken into account when choosing
                            the best study design to investigate your research question.
                        </ce:para>
                    </ce:list-item>
                    <ce:list-item id="u0635">
                        <ce:label>•</ce:label>
                        <ce:para id="p0800">In reality, the following four key issues are usually taken into account:
                            <ce:list id="l0180">
                                <ce:list-item id="o0055">
                                    <ce:label>1.</ce:label>
                                    <ce:para id="p0805">The aim of the study</ce:para>
                                </ce:list-item>
                                <ce:list-item id="o0060">
                                    <ce:label>2.</ce:label>
                                    <ce:para id="p0810">The advantages and disadvantages of different study designs
                                    </ce:para>
                                </ce:list-item>
                                <ce:list-item id="o0065">
                                    <ce:label>3.</ce:label>
                                    <ce:para id="p0815">The resources available</ce:para>
                                </ce:list-item>
                                <ce:list-item id="o0070">
                                    <ce:label>4.</ce:label>
                                    <ce:para id="p0820">Ethical considerations.</ce:para>
                                </ce:list-item>
                            </ce:list>
                        </ce:para>
                    </ce:list-item>
                    <ce:list-item id="u0640">
                        <ce:label>•</ce:label>
                        <ce:para id="p0825">The advantages and disadvantages of the various types of studies covered
                            above will be discussed in their respective chapters.
                        </ce:para>
                    </ce:list-item>
                    <ce:list-item id="u0645">
                        <ce:label>•</ce:label>
                        <ce:para id="p0830">Earlier in this chapter we introduced the idea that both interventional and
                            observational studies play a role in clinical research. Once you've decided on your broad
                            study design, the next step is to determine which type of study (e.g. cohort, case–control)
                            best answers the research question.
                        </ce:para>
                    </ce:list-item>
                    <ce:list-item id="u0650">
                        <ce:label>•</ce:label>
                        <ce:para id="p0835">The flowchart shown in
                            <ce:cross-ref refid="f0025">Fig. 5.4</ce:cross-ref>
                            <ce:float-anchor refid="f0025"/>
                            may assist you in choosing among the different types of study designs.
                        </ce:para>
                    </ce:list-item>
                    <ce:list-item id="u0655">
                        <ce:label>•</ce:label>
                        <ce:para id="p0840">As shown in<ce:cross-ref refid="f0025">Fig. 5.4</ce:cross-ref>, it would be
                            sensible to use a case–control or retrospective cohort study rather than a prospective
                            cohort study:
                            <ce:list id="l0185">
                                <ce:list-item id="u0660">
                                    <ce:label>•</ce:label>
                                    <ce:para id="p0845">if the outcome is rare.</ce:para>
                                </ce:list-item>
                                <ce:list-item id="u0665">
                                    <ce:label>•</ce:label>
                                    <ce:para id="p0850">if there is a relatively long time lag between the exposure and
                                        the outcome. This is also known as a long induction and latent period.
                                    </ce:para>
                                </ce:list-item>
                                <ce:list-item id="u0670">
                                    <ce:label>•</ce:label>
                                    <ce:para id="p0855">if there is a dynamic population due, for instance, to people
                                        moving in or out of the area. This is because it would be difficult to keep
                                        track of study participants who live in a population that is constantly
                                        changing; a fixed source population is preferred for cohort studies.
                                    </ce:para>
                                </ce:list-item>
                            </ce:list>
                        </ce:para>
                    </ce:list-item>
                </ce:list>
            </ce:para>
            <ce:section id="s0120">
                <ce:section-title id="st0125">Using the hierarchy of evidence</ce:section-title>
                <ce:para id="p0860">
                    <ce:list id="l0190">
                        <ce:list-item id="u0675">
                            <ce:label>•</ce:label>
                            <ce:para id="p0865">If a lot of research has already been carried out on the research
                                question but there is no obvious answer, it may be appropriate to carry out a systematic
                                review and meta-analysis.
                            </ce:para>
                        </ce:list-item>
                        <ce:list-item id="u0680">
                            <ce:label>•</ce:label>
                            <ce:para id="p0870">If observational studies show there is an association between two
                                variables, but you are unsure whether there is a causal link between them, it may be
                                appropriate to carry out an interventional study.
                            </ce:para>
                        </ce:list-item>
                        <ce:list-item id="u0685">
                            <ce:label>•</ce:label>
                            <ce:para id="p0875">If ecological or case–control studies have shown that there may be an
                                association between two variables, moving up the hierarchy of evidence (discussed in
                                <ce:intra-ref xlink:href="pii:B978-0-7234-3869-4.00001-X" id="ia0055">Chapter
                                    1</ce:intra-ref>), the next step may be to carry out a cohort study. However, if a
                                number of case reports suggest that there may be an association between two variables,
                                jumping straight to a cohort study would not be rational. It would be sensible to first
                                gather additional evidence of association using a cheaper and less resource intensive
                                study, such as using an ecological or cross-sectional study design. The graph shown in
                                <ce:cross-ref refid="f0030">Fig. 5.5</ce:cross-ref>
                                <ce:float-anchor refid="f0030"/>, which is based on the hierarchy of evidence,
                                illustrates this point.
                            </ce:para>
                        </ce:list-item>
                        <ce:list-item id="u0690">
                            <ce:label>•</ce:label>
                            <ce:para id="p0880">Referring to<ce:cross-ref refid="f0030">Fig. 5.5</ce:cross-ref>, it is
                                important to understand the following key points:
                                <ce:list id="l0195">
                                    <ce:list-item id="u0695">
                                        <ce:label>•</ce:label>
                                        <ce:para id="p0885">You are able to obtain more reliable evidence of causality
                                            from studies which are higher up in the hierarchy of evidence.
                                        </ce:para>
                                    </ce:list-item>
                                    <ce:list-item id="u0700">
                                        <ce:label>•</ce:label>
                                        <ce:para id="p0890">The initial discovery of a possible association between two
                                            variables doesn't always come from a case report. In other words, the
                                            starting point on the time axis (horizontal axis) isn't fixed.
                                        </ce:para>
                                    </ce:list-item>
                                    <ce:list-item id="u0705">
                                        <ce:label>•</ce:label>
                                        <ce:para id="p0895">If a study shows there may be an association between two
                                            variables, studies higher up in the hierarchy of evidence don't always agree
                                            with this finding. Therefore, time doesn't always equate to gathering more
                                            evidence of causality (despite the graph showing otherwise).
                                        </ce:para>
                                    </ce:list-item>
                                </ce:list>
                            </ce:para>
                        </ce:list-item>
                    </ce:list>
                </ce:para>
            </ce:section>
        </ce:section>
        <ce:section id="s0125">
            <ce:section-title id="st0130">WRITING UP A RESEARCH STUDY</ce:section-title>
            <ce:para id="p0900">
                <ce:list id="l0200">
                    <ce:list-item id="u0710">
                        <ce:label>•</ce:label>
                        <ce:para id="p0905">The following guideline can be used for writing most types of research
                            studies (e.g. cohort, case–control, cross-sectional).
                        </ce:para>
                    </ce:list-item>
                    <ce:list-item id="u0715">
                        <ce:label>•</ce:label>
                        <ce:para id="p0910">There are separate specific guidelines on how to report systematic reviews (
                            <ce:intra-ref xlink:href="pii:B978-0-7234-3869-4.00004-5" id="ia0060">Chapter
                                4</ce:intra-ref>), RCTs (<ce:intra-ref xlink:href="pii:B978-0-7234-3869-4.00006-9"
                                                                       id="ia0065">Chapter 6</ce:intra-ref>) and case
                            reports (<ce:intra-ref xlink:href="pii:B978-0-7234-3869-4.00011-2" id="ia0070">Chapter
                                11</ce:intra-ref>).
                        </ce:para>
                    </ce:list-item>
                    <ce:list-item id="u0720">
                        <ce:label>•</ce:label>
                        <ce:para id="p0915">The following guideline will cover the following sections:
                            <ce:list id="l0205">
                                <ce:list-item id="u0725">
                                    <ce:label>•</ce:label>
                                    <ce:para id="p0920">Title</ce:para>
                                </ce:list-item>
                                <ce:list-item id="u0730">
                                    <ce:label>•</ce:label>
                                    <ce:para id="p0925">Abstract</ce:para>
                                </ce:list-item>
                                <ce:list-item id="u0735">
                                    <ce:label>•</ce:label>
                                    <ce:para id="p0930">Introduction</ce:para>
                                </ce:list-item>
                                <ce:list-item id="u0740">
                                    <ce:label>•</ce:label>
                                    <ce:para id="p0935">Methods</ce:para>
                                </ce:list-item>
                                <ce:list-item id="u0745">
                                    <ce:label>•</ce:label>
                                    <ce:para id="p0940">Results</ce:para>
                                </ce:list-item>
                                <ce:list-item id="u0750">
                                    <ce:label>•</ce:label>
                                    <ce:para id="p0945">Discussion</ce:para>
                                </ce:list-item>
                                <ce:list-item id="u0755">
                                    <ce:label>•</ce:label>
                                    <ce:para id="p0950">References.</ce:para>
                                </ce:list-item>
                            </ce:list>
                        </ce:para>
                    </ce:list-item>
                </ce:list>
            </ce:para>
            <ce:section id="s0130">
                <ce:section-title id="st0135">Title</ce:section-title>
                <ce:para id="p0955">
                    <ce:list id="l0210">
                        <ce:list-item id="u0760">
                            <ce:label>•</ce:label>
                            <ce:para id="p0960">The title is essentially a highly condensed version of the abstract.
                            </ce:para>
                        </ce:list-item>
                        <ce:list-item id="u0765">
                            <ce:label>•</ce:label>
                            <ce:para id="p0965">Your objective is to use the fewest number of words to accurately
                                describe the content of the paper.
                            </ce:para>
                        </ce:list-item>
                    </ce:list>
                </ce:para>
            </ce:section>
            <ce:section id="s0135">
                <ce:section-title id="st0140">Abstract</ce:section-title>
                <ce:para id="p0970">
                    <ce:list id="l0215">
                        <ce:list-item id="u0770">
                            <ce:label>•</ce:label>
                            <ce:para id="p0975">There is usually a strict word limit for the abstract, so carefully read
                                the journal guidelines before you begin!
                            </ce:para>
                        </ce:list-item>
                        <ce:list-item id="u0775">
                            <ce:label>•</ce:label>
                            <ce:para id="p0980">The abstract will help readers discern whether they are interested (or
                                not) in reading the research report.
                            </ce:para>
                        </ce:list-item>
                        <ce:list-item id="u0780">
                            <ce:label>•</ce:label>
                            <ce:para id="p0985">For obvious reasons, the abstract is written after the rest of the paper
                                is completed.
                            </ce:para>
                        </ce:list-item>
                        <ce:list-item id="u0785">
                            <ce:label>•</ce:label>
                            <ce:para id="p0990">As it is a summary of the work done, it should be written in the past
                                tense.
                            </ce:para>
                        </ce:list-item>
                        <ce:list-item id="u0790">
                            <ce:label>•</ce:label>
                            <ce:para id="p0995">Complete sentences should be used to summarise the following elements of
                                the study:
                                <ce:list id="l0220">
                                    <ce:list-item id="u0795">
                                        <ce:label>•</ce:label>
                                        <ce:para id="p1000">Purpose of the study – Background to the study, research
                                            question and objectives.
                                        </ce:para>
                                    </ce:list-item>
                                    <ce:list-item id="u0800">
                                        <ce:label>•</ce:label>
                                        <ce:para id="p1005">Methods – Brief description of the study protocol.</ce:para>
                                    </ce:list-item>
                                    <ce:list-item id="u0805">
                                        <ce:label>•</ce:label>
                                        <ce:para id="p1010">Results – Specific summarised data should be included; the
                                            results of any important statistical tests should be stated, including the
                                            confidence interval and<ce:italic>P</ce:italic>-value.
                                        </ce:para>
                                    </ce:list-item>
                                    <ce:list-item id="u0810">
                                        <ce:label>•</ce:label>
                                        <ce:para id="p1015">Discussion – Important reflective points.</ce:para>
                                    </ce:list-item>
                                    <ce:list-item id="u0815">
                                        <ce:label>•</ce:label>
                                        <ce:para id="p1020">Conclusion – Key finding/s from the study; any questions
                                            that follow from the study.
                                        </ce:para>
                                    </ce:list-item>
                                </ce:list>
                            </ce:para>
                        </ce:list-item>
                        <ce:list-item id="u0820">
                            <ce:label>•</ce:label>
                            <ce:para id="p1025">The abstract should be engaging and to the point, highlighting only the
                                key details from the main text.
                            </ce:para>
                        </ce:list-item>
                    </ce:list>
                </ce:para>
            </ce:section>
            <ce:section id="s0140">
                <ce:section-title id="st0145">Introduction</ce:section-title>
                <ce:para id="p1030">
                    <ce:list id="l0225">
                        <ce:list-item id="u0825">
                            <ce:label>•</ce:label>
                            <ce:para id="p1035">You should grab the readers' attention at the start of the introduction,
                                highlighting the important issues that your paper addresses.
                            </ce:para>
                        </ce:list-item>
                        <ce:list-item id="u0830">
                            <ce:label>•</ce:label>
                            <ce:para id="p1040">The purpose of the Introduction is to discuss the rationale behind the
                                study.
                            </ce:para>
                        </ce:list-item>
                        <ce:list-item id="u0835">
                            <ce:label>•</ce:label>
                            <ce:para id="p1045">The opening sentence should take the reader straight to the issue.
                            </ce:para>
                        </ce:list-item>
                        <ce:list-item id="u0840">
                            <ce:label>•</ce:label>
                            <ce:para id="p1050">It is important to refrain from describing everything that is known
                                about the topic. Instead, you should set the scene, citing the best evidence available,
                                ideally from systematic reviews.
                            </ce:para>
                        </ce:list-item>
                        <ce:list-item id="u0845">
                            <ce:label>•</ce:label>
                            <ce:para id="p1055">By the end of the introduction, the reader should understand:
                                <ce:list id="l0230">
                                    <ce:list-item id="u0850">
                                        <ce:label>•</ce:label>
                                        <ce:para id="p1060">why your research was needed.</ce:para>
                                    </ce:list-item>
                                    <ce:list-item id="u0855">
                                        <ce:label>•</ce:label>
                                        <ce:para id="p1065">what was innovative about your work.</ce:para>
                                    </ce:list-item>
                                    <ce:list-item id="u0860">
                                        <ce:label>•</ce:label>
                                        <ce:para id="p1070">whether any controversies were addressed.</ce:para>
                                    </ce:list-item>
                                    <ce:list-item id="u0865">
                                        <ce:label>•</ce:label>
                                        <ce:para id="p1075">who will potentially benefit from the research.</ce:para>
                                    </ce:list-item>
                                </ce:list>
                            </ce:para>
                        </ce:list-item>
                        <ce:list-item id="u0870">
                            <ce:label>•</ce:label>
                            <ce:para id="p1080">The Introduction should end with a clear research question, i.e. a
                                specific hypothesis/objective.
                            </ce:para>
                        </ce:list-item>
                        <ce:list-item id="u0875">
                            <ce:label>•</ce:label>
                            <ce:para id="p1085">You should write the various sections of the paper using the active
                                voice rather than the passive voice. For example, ‘We compared the effect of drug A with
                                …’ rather than ‘The effect of drug A was compared to …’.
                            </ce:para>
                        </ce:list-item>
                    </ce:list>
                </ce:para>
            </ce:section>
            <ce:section id="s0145">
                <ce:section-title id="st0150">Methods</ce:section-title>
                <ce:para id="p1090">
                    <ce:list id="l0235">
                        <ce:list-item id="u0880">
                            <ce:label>•</ce:label>
                            <ce:para id="p1095">The objective of this section is to document all the methods used in
                                your study, so that a reader would know exactly how to repeat the study.
                            </ce:para>
                        </ce:list-item>
                        <ce:list-item id="u0885">
                            <ce:label>•</ce:label>
                            <ce:para id="p1100">If necessary, you should include a clear statement of ethics committee
                                approval and that subjects gave their informed consent for participating in the study.
                            </ce:para>
                        </ce:list-item>
                        <ce:list-item id="u0890">
                            <ce:label>•</ce:label>
                            <ce:para id="p1105">For studies handling quantitative data, you should:
                                <ce:list id="l0240">
                                    <ce:list-item id="u0895">
                                        <ce:label>•</ce:label>
                                        <ce:para id="p1110">specify the study design (e.g. observational or
                                            interventional, prospective or retrospective, controlled or uncontrolled).
                                        </ce:para>
                                    </ce:list-item>
                                    <ce:list-item id="u0900">
                                        <ce:label>•</ce:label>
                                        <ce:para id="p1115">describe how and why you chose the study sample, including
                                            details on:
                                            <ce:list id="l0245">
                                                <ce:list-item id="u0905">
                                                    <ce:label>•</ce:label>
                                                    <ce:para id="p1120">how the sample size was determined. Was a sample
                                                        size calculation performed prior to starting the study?
                                                    </ce:para>
                                                </ce:list-item>
                                                <ce:list-item id="u0910">
                                                    <ce:label>•</ce:label>
                                                    <ce:para id="p1125">how participants were recruited for the study.
                                                    </ce:para>
                                                </ce:list-item>
                                                <ce:list-item id="u0915">
                                                    <ce:label>•</ce:label>
                                                    <ce:para id="p1130">the sampling strategy, i.e. how you ensured the
                                                        sample was representative of the population you chose to study.
                                                    </ce:para>
                                                </ce:list-item>
                                                <ce:list-item id="u0920">
                                                    <ce:label>•</ce:label>
                                                    <ce:para id="p1135">your inclusion and exclusion criteria.</ce:para>
                                                </ce:list-item>
                                                <ce:list-item id="u0925">
                                                    <ce:label>•</ce:label>
                                                    <ce:para id="p1140">any steps taken to ensure selection bias was
                                                        avoided.
                                                    </ce:para>
                                                </ce:list-item>
                                            </ce:list>
                                        </ce:para>
                                    </ce:list-item>
                                    <ce:list-item id="u0930">
                                        <ce:label>•</ce:label>
                                        <ce:para id="p1145">describe the intervention and the comparison group.
                                        </ce:para>
                                    </ce:list-item>
                                    <ce:list-item id="u0935">
                                        <ce:label>•</ce:label>
                                        <ce:para id="p1150">identify the main study outcome variables, including
                                            specific details on:
                                            <ce:list id="l0250">
                                                <ce:list-item id="u0940">
                                                    <ce:label>•</ce:label>
                                                    <ce:para id="p1155">what outcome was measured. Were there primary
                                                        and secondary outcomes?
                                                    </ce:para>
                                                </ce:list-item>
                                                <ce:list-item id="u0945">
                                                    <ce:label>•</ce:label>
                                                    <ce:para id="p1160">when the outcome was measured.</ce:para>
                                                </ce:list-item>
                                                <ce:list-item id="u0950">
                                                    <ce:label>•</ce:label>
                                                    <ce:para id="p1165">any steps taken to ensure measurement bias was
                                                        avoided.
                                                    </ce:para>
                                                </ce:list-item>
                                            </ce:list>
                                        </ce:para>
                                    </ce:list-item>
                                    <ce:list-item id="u0955">
                                        <ce:label>•</ce:label>
                                        <ce:para id="p1170">state which statistical methods were used to analyse your
                                            data.
                                        </ce:para>
                                    </ce:list-item>
                                </ce:list>
                            </ce:para>
                        </ce:list-item>
                        <ce:list-item id="u0960">
                            <ce:label>•</ce:label>
                            <ce:para id="p1175">For studies handling qualitative data, you should:
                                <ce:list id="l0255">
                                    <ce:list-item id="u0965">
                                        <ce:label>•</ce:label>
                                        <ce:para id="p1180">explain why a qualitative approach was appropriate for
                                            answering your research question (as opposed to a quantitative approach).
                                        </ce:para>
                                    </ce:list-item>
                                    <ce:list-item id="u0970">
                                        <ce:label>•</ce:label>
                                        <ce:para id="p1185">explain how you selected the study participants and in which
                                            setting.
                                        </ce:para>
                                    </ce:list-item>
                                    <ce:list-item id="u0975">
                                        <ce:label>•</ce:label>
                                        <ce:para id="p1190">describe what methods were used for collecting data.
                                        </ce:para>
                                    </ce:list-item>
                                    <ce:list-item id="u0980">
                                        <ce:label>•</ce:label>
                                        <ce:para id="p1195">describe what methods were used for analysing the data, and
                                            whether any quality control measures were implemented.
                                        </ce:para>
                                    </ce:list-item>
                                    <ce:list-item id="u0985">
                                        <ce:label>•</ce:label>
                                        <ce:para id="p1200">include specific details on any steps taken to avoid bias
                                            when collecting or analysing the data.
                                        </ce:para>
                                    </ce:list-item>
                                </ce:list>
                            </ce:para>
                        </ce:list-item>
                    </ce:list>
                    <ce:display>
                        <ce:textbox role="alt0" id="b0015">
                            <ce:textbox-head>
                                <ce:title>HINTS AND TIPS</ce:title>
                            </ce:textbox-head>
                            <ce:textbox-body>
                                <ce:sections>
                                    <ce:para id="p1205">The primary outcome variable is the outcome of greatest
                                        importance. Data on secondary outcomes are used to evaluate any additional
                                        effects caused by the intervention/exposure. It is usually the primary outcome
                                        on which sample size calculations are based.
                                    </ce:para>
                                </ce:sections>
                            </ce:textbox-body>
                        </ce:textbox>
                    </ce:display>
                </ce:para>
            </ce:section>
            <ce:section id="s0150">
                <ce:section-title id="st0155">Results</ce:section-title>
                <ce:para id="p1210">
                    <ce:list id="l0260">
                        <ce:list-item id="u0990">
                            <ce:label>•</ce:label>
                            <ce:para id="p1215">The purpose of the Results section is to present and illustrate your
                                findings.
                            </ce:para>
                        </ce:list-item>
                        <ce:list-item id="u0995">
                            <ce:label>•</ce:label>
                            <ce:para id="p1220">This section should be a completely
                                <ce:italic>objective</ce:italic>
                                report of the results.
                            </ce:para>
                        </ce:list-item>
                        <ce:list-item id="u1000">
                            <ce:label>•</ce:label>
                            <ce:para id="p1225">In summary, you should:
                                <ce:list id="l0265">
                                    <ce:list-item id="u1005">
                                        <ce:label>•</ce:label>
                                        <ce:para id="p1230">summarise your data in the main text and illustrate them, if
                                            appropriate, with tables and figures.
                                        </ce:para>
                                    </ce:list-item>
                                    <ce:list-item id="u1010">
                                        <ce:label>•</ce:label>
                                        <ce:para id="p1235">provide some context to a statistical test before describing
                                            the result, i.e. describe the question that is going to be addressed by a
                                            particular statistical test.
                                        </ce:para>
                                    </ce:list-item>
                                    <ce:list-item id="u1015">
                                        <ce:label>•</ce:label>
                                        <ce:para id="p1240">analyse the data using appropriate statistical tests,
                                            stating:
                                            <ce:list id="l0270">
                                                <ce:list-item id="u1020">
                                                    <ce:label>•</ce:label>
                                                    <ce:para id="p1245">the<ce:italic>P</ce:italic>-value
                                                    </ce:para>
                                                </ce:list-item>
                                                <ce:list-item id="u1025">
                                                    <ce:label>•</ce:label>
                                                    <ce:para id="p1250">the 95% confidence interval of the mean (or
                                                        proportion).
                                                    </ce:para>
                                                </ce:list-item>
                                            </ce:list>
                                        </ce:para>
                                    </ce:list-item>
                                </ce:list>
                            </ce:para>
                        </ce:list-item>
                        <ce:list-item id="u1030">
                            <ce:label>•</ce:label>
                            <ce:para id="p1255">You should avoid:
                                <ce:list id="l0275">
                                    <ce:list-item id="u1035">
                                        <ce:label>•</ce:label>
                                        <ce:para id="p1260">presenting the data more than once.</ce:para>
                                    </ce:list-item>
                                    <ce:list-item id="u1040">
                                        <ce:label>•</ce:label>
                                        <ce:para id="p1265">interpreting the results (save this for the Discussion
                                            section).
                                        </ce:para>
                                    </ce:list-item>
                                </ce:list>
                            </ce:para>
                        </ce:list-item>
                        <ce:list-item id="u1045">
                            <ce:label>•</ce:label>
                            <ce:para id="p1270">The text should complement any tables or figures, not repeat the same
                                information.
                            </ce:para>
                        </ce:list-item>
                        <ce:list-item id="u1050">
                            <ce:label>•</ce:label>
                            <ce:para id="p1275">As always, you should use the past tense when referring to your
                                results.
                            </ce:para>
                        </ce:list-item>
                    </ce:list>
                    <ce:display>
                        <ce:textbox role="alt0" id="b0020">
                            <ce:textbox-head>
                                <ce:title>HINTS AND TIPS</ce:title>
                            </ce:textbox-head>
                            <ce:textbox-body>
                                <ce:sections>
                                    <ce:para id="p1280">For each figure or table, you should remember to include a
                                        legend which:
                                        <ce:list id="l0280">
                                            <ce:list-item id="u1055">
                                                <ce:label>•</ce:label>
                                                <ce:para id="p1285">is numbered consecutively.</ce:para>
                                            </ce:list-item>
                                            <ce:list-item id="u1060">
                                                <ce:label>•</ce:label>
                                                <ce:para id="p1290">consists of a title.</ce:para>
                                            </ce:list-item>
                                            <ce:list-item id="u1065">
                                                <ce:label>•</ce:label>
                                                <ce:para id="p1295">conveys information about what the table or figure
                                                    tells the reader.
                                                </ce:para>
                                            </ce:list-item>
                                        </ce:list>
                                    </ce:para>
                                    <ce:para id="p1300">Each table or figure must be sufficiently complete so that it
                                        stands on its own, separate from the text.
                                    </ce:para>
                                </ce:sections>
                            </ce:textbox-body>
                        </ce:textbox>
                    </ce:display>
                </ce:para>
            </ce:section>
            <ce:section id="s0155">
                <ce:section-title id="st0160">Discussion</ce:section-title>
                <ce:para id="p1305">
                    <ce:list id="l0285">
                        <ce:list-item id="u1070">
                            <ce:label>•</ce:label>
                            <ce:para id="p1310">The objective of the Discussion is to provide an interpretation of your
                                results, using evidence from the literature to make your conclusions.
                            </ce:para>
                        </ce:list-item>
                        <ce:list-item id="u1075">
                            <ce:label>•</ce:label>
                            <ce:para id="p1315">The Discussion should start with a sentence that describes your
                                principal finding.
                            </ce:para>
                        </ce:list-item>
                        <ce:list-item id="u1080">
                            <ce:label>•</ce:label>
                            <ce:para id="p1320">The strengths and weaknesses of the study design should both be
                                discussed to help you interpret the validity of the findings.
                            </ce:para>
                        </ce:list-item>
                        <ce:list-item id="u1085">
                            <ce:label>•</ce:label>
                            <ce:para id="p1325">The results should be discussed with reference to previous research. Do
                                your results:
                                <ce:list id="l0290">
                                    <ce:list-item id="u1090">
                                        <ce:label>•</ce:label>
                                        <ce:para id="p1330">fit in with what is already known about the topic?</ce:para>
                                    </ce:list-item>
                                    <ce:list-item id="u1095">
                                        <ce:label>•</ce:label>
                                        <ce:para id="p1335">reach different conclusions to those stated in the
                                            literature? If so, why?
                                        </ce:para>
                                    </ce:list-item>
                                </ce:list>
                            </ce:para>
                        </ce:list-item>
                        <ce:list-item id="u1100">
                            <ce:label>•</ce:label>
                            <ce:para id="p1340">It is important to explain all your observations as much as possible.
                                For example:
                                <ce:list id="l0295">
                                    <ce:list-item id="u1105">
                                        <ce:label>•</ce:label>
                                        <ce:para id="p1345">what are the possible mechanisms linking one variable to
                                            another?
                                        </ce:para>
                                    </ce:list-item>
                                    <ce:list-item id="u1110">
                                        <ce:label>•</ce:label>
                                        <ce:para id="p1350">what are the policy and practice implications of your
                                            results?
                                        </ce:para>
                                    </ce:list-item>
                                </ce:list>
                            </ce:para>
                        </ce:list-item>
                        <ce:list-item id="u1115">
                            <ce:label>•</ce:label>
                            <ce:para id="p1355">You should end the Discussion with a paragraph highlighting any
                                questions left unanswered and ideas for future research.
                            </ce:para>
                        </ce:list-item>
                        <ce:list-item id="u1120">
                            <ce:label>•</ce:label>
                            <ce:para id="p1360">Again, refer to work done by specific individuals (including yourself)
                                in the past tense.
                            </ce:para>
                        </ce:list-item>
                    </ce:list>
                </ce:para>
            </ce:section>
            <ce:section id="s0160">
                <ce:section-title id="st0165">References</ce:section-title>
                <ce:para id="p1365">
                    <ce:list id="l0300">
                        <ce:list-item id="u1125">
                            <ce:label>•</ce:label>
                            <ce:para id="p1370">All sources of information referred to in the research paper should be
                                acknowledged in the references section at the end of the paper.
                            </ce:para>
                        </ce:list-item>
                        <ce:list-item id="u1130">
                            <ce:label>•</ce:label>
                            <ce:para id="p1375">The Harvard Referencing System is a collection of rules that
                                standardises the format in which common types of material (e.g. books, journal articles,
                                websites) are referenced.
                            </ce:para>
                        </ce:list-item>
                    </ce:list>
                </ce:para>
                <ce:section id="s0165">
                    <ce:section-title id="st0170">Journal articles</ce:section-title>
                    <ce:para id="p1380">Journal articles are usually laid out like this:</ce:para>
                    <ce:para id="p1385">Authors(s). (Year) Title of article.<ce:italic>Title of journal</ce:italic>.
                        Volume number (part/issue): Page number.
                    </ce:para>
                    <ce:para id="p1390">The title of the journal is usually abbreviated. For example,</ce:para>
                    <ce:para id="p1395">Doll R and Hill AB. (1954) The mortality of doctors in relation to their smoking
                        habits.<ce:italic>Br Med J</ce:italic>. 1(4877): 1451–1455.
                    </ce:para>
                </ce:section>
                <ce:section id="s0170">
                    <ce:section-title id="st0175">Books</ce:section-title>
                    <ce:para id="p1400">Books are usually laid out like this:</ce:para>
                    <ce:para id="p1405">Authors(s). (Year)<ce:italic>Title of book</ce:italic>. Edition. Place of
                        publication: Publisher.
                    </ce:para>
                    <ce:para id="p1410">For books with one or more editors, you include the abbreviation (ed.) or (eds)
                        after their surname. You only include the edition if the book is not in its first edition. For
                        example,
                    </ce:para>
                    <ce:para id="p1415">Khot A and Polmear A. (eds) (2010)<ce:italic>Practical General Practice:
                        Guidelines for Effective Clinical Management</ce:italic>. 6th edn. Edinburgh: Elsevier,
                        Churchill Livingstone.
                    </ce:para>
                </ce:section>
                <ce:section id="s0175">
                    <ce:section-title id="st0180">Chapters in books</ce:section-title>
                    <ce:para id="p1420">Chapters in books are usually laid out like this:</ce:para>
                    <ce:para id="p1425">Authors(s). (Year) Title of chapter. In: Author(s)/Editor(s).<ce:italic>Title of
                        book</ce:italic>. Edition. Place of publication: Publisher.
                    </ce:para>
                    <ce:para id="p1430">For example,</ce:para>
                    <ce:para id="p1435">Jeremy JY, Kaura A, Sablayrolles JL and Angelini GD. (2010) Saphenous vein graft
                        attrition. In: Escaned J and Serruys PW (eds)<ce:italic>Coronary Stenosis. Imaging, Structure
                            and Physiology</ce:italic>. Toulouse, France: PCR Publishing.
                    </ce:para>
                </ce:section>
                <ce:section id="s0180">
                    <ce:section-title id="st0185">Websites</ce:section-title>
                    <ce:para id="p1440">A website should be treated similarly to a print work; i.e. it should have an
                        author or editor and a title. You should include the
                        <ce:italic>full</ce:italic>
                        address of the website and also the date on which the page was accessed. Websites are usually
                        laid out like this:
                    </ce:para>
                    <ce:para id="p1445">Authors(s). (Year) Website title. Web address [accessed day month year].
                    </ce:para>
                    <ce:para id="p1450">For example,</ce:para>
                    <ce:para id="p1455">The foundation programme. (2012) Academic Programmes.
                        <ce:inter-ref xlink:href="http://www.foundationprogramme.nhs.uk/pages/academic-programmes"
                                      id="ir0010">http://www.foundationprogramme.nhs.uk/pages/academic-programmes
                        </ce:inter-ref>
                        [accessed 14 May 2012].
                    </ce:para>
                </ce:section>
                <ce:section id="s0185">
                    <ce:section-title id="st0190">Dissertations and theses</ce:section-title>
                    <ce:para id="p1460">These are usually laid out like this:</ce:para>
                    <ce:para id="p1465">Authors(s). (Year)<ce:italic>Title</ce:italic>. Designation (Level, e.g. MSc,
                        PhD), Institution.
                    </ce:para>
                    <ce:para id="p1470">If the piece of work has not been published, you include this after the title.
                        For example,
                    </ce:para>
                    <ce:para id="p1475">Wayne B. (2012)
                        <ce:italic>How I Became Batman!</ce:italic>
                        Unpublished dissertation (MSc), DC University.
                    </ce:para>
                </ce:section>
                <ce:section id="s0190">
                    <ce:section-title id="st0195">Verbal materials: interviews</ce:section-title>
                    <ce:para id="p1480">Interviews are usually laid out like this:</ce:para>
                    <ce:para id="p1485">Named Person(s). (Year)<ce:italic>Title for interview</ce:italic>. Conducted by
                        (name) on (date) at (location).
                    </ce:para>
                    <ce:para id="p1490">For example,</ce:para>
                    <ce:para id="p1495">Simpson H. (2012)<ce:italic>Interview on the World's Best Doughnut</ce:italic>.
                        Conducted by Kaura A, on 21 November 2010 at Springfield nuclear power plant, USA.
                    </ce:para>
                </ce:section>
                <ce:section id="s0195">
                    <ce:section-title id="st0200">Unpublished material: lecture notes</ce:section-title>
                    <ce:para id="p1500">Lecture notes are usually laid out like this:</ce:para>
                    <ce:para id="p1505">Lecturer(s). (Year)<ce:italic>Title of lecture</ce:italic>. Course/module name,
                        Institution where delivered, Date delivered [Lecture notes taken by (name)].
                    </ce:para>
                    <ce:para id="p1510">For example,</ce:para>
                    <ce:para id="p1515">Parker P. (1984)
                        <ce:italic>How to Become a Spiderman (or Spiderwoman)!</ce:italic>
                        BSc Genetics, Marvel University, 14 June 1984 [Lecture notes taken by Kaura A].
                    </ce:para>
                </ce:section>
            </ce:section>
        </ce:section>
    </ce:sections>
</chapter>